AMBEY2025-04-012025-09-30AMBEY2025-09-30AMBEY2025-03-31AMBEY2025-04-012025-09-30in-capmkt:OtherExpenses1MemberAMBEY2025-04-012025-09-30RelatedPartyTransactionDomain1AMBEY2025-03-31RelatedPartyTransactionDomain1AMBEY2025-09-30RelatedPartyTransactionDomain1AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain2AMBEY2025-03-31RelatedPartyTransactionDomain2AMBEY2025-09-30RelatedPartyTransactionDomain2AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain3AMBEY2025-03-31RelatedPartyTransactionDomain3AMBEY2025-09-30RelatedPartyTransactionDomain3AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain4AMBEY2025-03-31RelatedPartyTransactionDomain4AMBEY2025-09-30RelatedPartyTransactionDomain4AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain5AMBEY2025-03-31RelatedPartyTransactionDomain5AMBEY2025-09-30RelatedPartyTransactionDomain5AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain6AMBEY2025-03-31RelatedPartyTransactionDomain6AMBEY2025-09-30RelatedPartyTransactionDomain6AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain7AMBEY2025-03-31RelatedPartyTransactionDomain7AMBEY2025-09-30RelatedPartyTransactionDomain7AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain8AMBEY2025-03-31RelatedPartyTransactionDomain8AMBEY2025-09-30RelatedPartyTransactionDomain8AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain9AMBEY2025-03-31RelatedPartyTransactionDomain9AMBEY2025-09-30RelatedPartyTransactionDomain9AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain10AMBEY2025-03-31RelatedPartyTransactionDomain10AMBEY2025-09-30RelatedPartyTransactionDomain10AMBEY2025-04-012025-09-30RelatedPartyTransactionDomain11AMBEY2025-03-31RelatedPartyTransactionDomain11AMBEY2025-09-30RelatedPartyTransactionDomain110000002025-09-30Statement10000002025-04-012025-09-30Statement1AMBEY2025-09-30StatementDynamic1I1Statement1AMBEY2025-09-30StatementDynamic1I2Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000AMBEYNOTLISTEDINE0M3I01029Ambey Laboratories LimitedSMEEquity2025-04-012026-03-312025-11-142025-11-06INRLakhsHalf YearlyHalf yearlySingle segmentPesticides & Agrochemical2025-11-1418:45:002025-11-1419:30:00trueCash Flow IndirectNot applicabletruetrueNANAfalsetrue2024-02-02https://ambeylab.com/policies/true1falseThe Comapany has not made any default on Loans and Debt Securities2025-04-012025-09-30UnauditedStandalone68175900013370006830960006176510000-22646000770100019211000110090002011300065303900030057000030057000030057000038400003840000262170000002621700026217000249468000101.051.05Other expenses20113000249468000540251000125003000914722000001893410000053590000194700000210878000695300046895000538480001554100010977000291244000140066600021508600005081000017177500003919420001000000103650000411220000444429000030612400049976800060840001037900012831100055710009562370001400666000192110001100900000000-4290000029791000-6992000-95449000-24378000-12459000-3733000136000-142875000-113084000-8302700000000-8302700000-8302700001000000000000015151000000000042900001790000-1554300000-1554300001250030000818590009007000001921100000975810000097581000-9890000-98900072760006287000Ambey Laboratories Limited******Aromatic Rasayan Private Limited******Common Directors and shareholders between both the partiesSale of goods or services0NA18000000002025-04-04203400000016612000Ambey Laboratories Limited******Aromatic Rasayan Private Limited******Common Directors and shareholders between both the partiesPurchase of goods or services0NA18000000002025-04-04556400000103500000Ambey Laboratories Limited******Dhansa Consumers Private Limited******Common Directors and shareholders between both the partiesSale of goods or services50000000NA02025-04-04113120002012400027218000Ambey Laboratories Limited******Archit Gupta******WTD, CEO and PromoterRemuneration1200000NA6000009400094000Ambey Laboratories Limited******Rishita Gupta******PromoterRemuneration1200000NA6000009400094000Ambey Laboratories Limited******Sarina Gupta******PromoterRemunerationNA600000094000Ambey Laboratories Limited******Arpit Gupta******Director and PromoterRemuneration1200000NA100000094000Ambey Laboratories Limited******Sarvar Alam******KMP-CFORemuneration1200000NA420000068000Ambey Laboratories Limited******Himanshu Kukreja******KMP-CSRemuneration0NA372000062000Ambey Laboratories Limited******Roni Soni******Independent DirectorAny other transactionSitting Fee0NA27000014000Ambey Laboratories Limited******Abdul Quadir******Independent DirectorAny other transactionSitting Fee0NA1400000773845000Preferential Issues2025-07-26499999990000002025-09-30falsefalseDuring the half year ended on 30 September 2025, the Company issued 1,08,69,565 Convertible Equity Warrants to public category investors at an issue price of Rs. 46/- per warrant, against receipt of 25% of the allotment money, in accordance with Sections 42 and 62(1)(c) of the Companies Act, 2013 and other applicable provisions. The warrants remain outstanding and pending conversion as at the reporting date. The 25% money received against these warrants has been utilized for the purposes detailed in the table below.Archit GuptaCEOGurugram2025-11-14To purchase land, building, plant and machinerynot applicable450000000000000108299160000000General Corporate Purposenot applicable4999999000000016700838000000